Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

You are here

Home » Ristova 500 mg Injection ( Rituximab)
Connect with this vendor - Learn about this product
Add to Favourite List
Request Info
View Catalogs

Ristova 500 mg Injection ( Rituximab)

MBA Pharmaceuticals Pvt Ltd
Category: 
Pharma & Supplements
Drugs

Manufacturer: Roche Products India Pvt Ltd

Medicine composition: Rituximab

Ristova 500Mg Injection acts as a monoclonal antibody. This drug is relatively new and is used to offer targeted therapy to treat cancer. Ristova 500Mg Injection only targets cancer cells in the body, thus the drug is less harmful as compared to Ristova 500Mg Injection radiation treatment.

Ristova 500Mg Injection is used to treat chronic lymphocytic leukemia and some types of non-hodgkin’s lymphoma.

 

Specialty: 
Oncology
View this product at mbapharmaceuticals.com
We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy and Cookie Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree